(Press-News.org) In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have engineered polymer-based nanoparticles that form with a simple temperature shift—no harsh chemicals, no specialized equipment, and no processing needed.
The new nanoparticles, described in Nature Biomedical Engineering, self-assemble at room-temperature in water and, because of these gentle conditions, can deliver proteins, which are unstable in many existing nanoparticle formulations.
“What excites me about this platform is its simplicity and versatility. By simply warming a sample from fridge temperature to room temperature, we can reliably make nanoparticles that are ready to deliver a wide variety of biological drugs,” said co-senior author Stuart Rowan, the Barry L. MacLean Professor for Molecular Engineering Innovation and Enterprise at UChicago Pritzker Molecular Engineering and a staff scientist Argonne National Laboratory.
From problem to platform
Nanoparticles are key to protecting delicate drugs like RNA and proteins from being degraded in the body before they reach the right cells. Lipid nanoparticles (LNPs), made of fatty molecules, enabled the COVID-19 mRNA vaccines, for instance. But LNPs rely on alcohol-based solvents and sensitive manufacturing steps—making them poorly suited for protein delivery and hard to scale.
“We wanted to make a delivery system that could work for both RNA and protein therapies—because right now, most platforms are specialized for just one,” said first author Samir Hossainy, a UChicago PME graduate student. “We also wanted to make it scalable, without needing toxic solvents or complicated microfluidics.”
Hossainy hypothesized that polymer-based nanoparticles could offer a more robust, customizable alternative. He outlined the required characteristics; the immune system will only respond to particles with certain sizes, shapes, and charges. Then, he used chemical tools to begin designing new nanoparticles from scratch.
After trying, and fine-tuning, more than a dozen different materials, he found one that worked. In cold water, the polymer—and any desired protein—remained dissolved. But when heated to room temperature, the polymer self-assembled into uniformly sized nanoparticles (or “polymersomes”) surrounding the protein molecules.
“Our particle size and morphology is dictated only by the chemistry of the polymers that I designed from the bottom up,” explained Hossainy. “We don’t have to worry about different particle sizes forming, which is a challenge with a lot of today’s nanoparticles.”
Carrying versatile cargo
To test the new polymersomes, Hossainy worked with colleagues in Rowan’s lab as well as with former UChicago PME Prof. Jeffrey Hubbell, now at New York University. First, they showed that the particles can encapsulate more than 75% of protein and nearly 100% of short interfering RNA (siRNA) cargo—far higher than most current systems—and they can be freeze-dried and stored without refrigeration until needed.
In the context of vaccination, Hossainy and his collaborators found that the polymersomes could effectively carry a protein and, when injected into mice, lead the animals’ immune systems to generate long-lasting antibodies against that protein. Another experiment showed that the nanoparticles could also carry proteins designed to prevent an immune response in the context of allergic asthma. And a third showed that injecting polymersomes into tumors could block cancer-related genes and suppress tumor growth in mice.
“The exciting thing is that we didn't need to tailor a different system for each use case,” said Hossainy. “This one formulation worked for everything we tried—proteins, RNA, immune activation, immune suppression, and direct tumor targeting.”
A scalable solution for worldwide vaccines
One of the biggest advantages of the new polymersomes over current LNPs is the potential for low-tech, decentralized production. Hossainy says he imagines being able to ship freeze-dried formulations of the nanoparticles to anywhere in the world. When they need to be used, they can be mixed in cold water, warmed up, and will be ready to deliver to patients.
“Being able to store these dry drastically improves the stability of the RNA or protein,” said Hossainy.
The group is continuing to work on fine-turning the particles to carry more types of cargo, including messenger RNA like that used in the COVID-19 vaccines (generally much larger than the siRNA used in the current trial). They also plan to collaborate on pre-clinical trials to apply the polymersomes to real-world vaccine or drug delivery challenges.
Citation: “Thermoreversibly Assembled Polymersomes for Highly Efficient Loading, Processing, and Delivery of Protein and siRNA Biologics,” Hossainy et al, Nature Biomedical Engineering, August 6, 2025. DOI: 10.1038/s41551-025-01469-7
Funding: This work was supported by the National Institute of Allergy and Infectious Diseases (75N93019C00041) and the Chicago Immunoengineering Innovation Center.
END
Nanoparticles that self-assemble at room temperature could transform vaccine delivery
Researchers from UChicago Pritzker Molecular Engineering created drug delivery nanoparticles that self-assemble with a simple temperature shift
2025-08-06
ELSE PRESS RELEASES FROM THIS DATE:
With just a few messages, biased AI chatbots swayed people’s political views
2025-08-06
If you’ve interacted with an artificial intelligence chatbot, you’ve likely realized that all AI models are biased. They were trained on enormous corpuses of unruly data and refined through human instructions and testing. Bias can seep in anywhere. Yet how a system’s biases can affect users is less clear.
So a University of Washington study put it to the test. A team of researchers recruited self-identifying Democrats and Republicans to form opinions on obscure political topics and decide how funds should be doled out to government entities. For help, they were ...
Potatoes may increase risk of type 2 diabetes—depending on their preparation
2025-08-06
Embargoed for release: Wednesday, August 6, 6:30 PM ET
Key points:
In a study that tracked the diets of more than 205,000 adults over decades, three servings weekly of French fries was associated with a 20% excess risk of developing type 2 diabetes (T2D). There was no significant association between consumption of baked, boiled, or mashed potatoes and risk of diabetes. However, swapping any form of potatoes for whole grains was estimated to lower T2D risk.
The study offers the most comprehensive findings on potatoes and T2D risk to date. Prior studies have ...
Three weekly servings of French fries linked to higher diabetes risk
2025-08-06
Eating three servings of French fries a week is associated with a 20% increased risk of developing type 2 diabetes, but eating similar amounts of potatoes cooked in other ways - boiled, baked or mashed - does not substantially increase the risk, finds a study published by The BMJ today.
What’s more, replacing any form of potatoes with whole grains was associated with a lower type 2 diabetes risk, but swapping them for white rice was linked to an increased risk, the results show.
Potatoes contain several nutrients including fibre, vitamin C, and magnesium, but they also have a high starch content and therefore a high glycemic index, so have been linked to a ...
Global hunt for ‘positive tipping points’
2025-08-06
Experts are calling for a global effort to identify “positive tipping points” to accelerate the green transition – and have devised a method to find them.
A tipping point is a threshold where a small change can trigger a significant, often irreversible, transformation.
With climate change becoming increasingly damaging and dangerous, positive tipping points in human societies and economies can spark rapid reductions in emissions and other environmental harm.
Positive tipping points are already happening – with solar power and electric vehicles rapidly displacing fossil-fuelled alternatives – but many more are needed to ensure a thriving, sustainable ...
Getting the most out of therapy – Therapists report what you should know before starting
2025-08-06
Of 1.7 million referrals for therapy in 2022-23, more than 1 million people dropped out before starting or during their therapy. This represents a dropout rate of over 60%. Many patients report worries about therapy, uncertainty about the process, and ill-preparedness for the journey ahead as to why they didn’t engage.
Using the scientific Delphi Consensus approach with 41 therapists, researchers from Warwick Medical School, University of Warwick, have published a report in BMJ Open listing recommendations for things people should know, and steps they can try, while awaiting therapy ...
Clean energy is here. Getting it to EVs isn’t
2025-08-06
Even if enough renewable energy is available, simply switching from gas-powered cars to electric vehicles (EVs) won’t be enough to fight climate change — unless the U.S. also upgrades its transmission grid, a new Northwestern University study finds.
If every gas-powered vehicle in the U.S. were replaced by an EV, transmission constraints would prevent the cleanest available electricity from reaching many charging locations. This “grid congestion” would force greater reliance on nearby fossil fuel power plants, undercutting the emissions benefits of electrification.
After identifying the issue, the study also recommends a modest set of targeted ...
Study: Affordable trial programs prevented youth substance misuse
2025-08-06
While overdose deaths in the U.S. sharply declined in 2024, they remain high. Almost 90,000 Americans died from drug overdoses between October 2023 and September 2024. Overdose death rates are particularly high in American Indian and Alaska Native (AI/AN) people.
The earlier someone starts substance use, the more likely they are to have substance use problems later in life. So, it is important to work with young people to prevent substance use early in life. Researchers at Emory’s Rollins School of Public Health recently partnered ...
Better access to technology can help African Americans bridge the healthcare gap
2025-08-06
(Santa Barbara, Calif.) — Researchers at UC Santa Barbara have found that better access to technology can go a long way toward achieving equity in healthcare for African Americans in the United States. According to Sharon Tettegah and Ebenezer Larnyo, both researchers at UCSB’s Center for Black Studies Research (CBSR), leveraging health technology is a promising strategy for addressing longstanding healthcare disparities “by enhancing access to care, improving its quality and reducing inequities.”
“Our study shows that improving access to technology like broadband internet and smartphones, and healthcare technology use like ...
Higher risk of ischemic stroke at young age after pregnancy complications
2025-08-06
The study examined over a thousand women aged 18 to 49. Of these, 358 had suffered an ischemic stroke. Researchers compared the pregnancy histories of these women with those of 714 women who had not experienced a stroke. The results showed that more than half of the women who had an ischemic stroke had experienced at least one complication during pregnancy. In the group without ischemic stroke, this was one-third.
Women who had experienced a stillbirth were found to be nearly five times more likely to ...
Complicated pregnancies linked to higher risk of early stroke
2025-08-06
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, AUGUST 6, 2025
MINNEAPOLIS – Experiencing complications during pregnancy is linked with a higher risk of stroke before age 50, according to a study published August 6, 2025, in Neurology®, the medical journal of the American Academy of Neurology. Researchers found female participants who had certain pregnancy complications were more likely to have an early stroke. These included preeclampsia, preterm birth, gestational diabetes, miscarriage and stillbirth. The study does not prove that pregnancy complications cause stroke. It only shows an association.
“While the ...
LAST 30 PRESS RELEASES:
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
Retinitis pigmentosa mouse models reflect pathobiology of human RP59
Cell’s ‘antenna’ could be key to curing diseases
Tiny ocean partnership between algae and bacteria reveals secrets of evolution
Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy
Blocking protein control pathway slows rhabdomyosarcoma growth in mice
2026 Hertz Fellowship Application Now Open
The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics
ADHD drugs are being prescribed too quickly to preschoolers
UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer
Extreme heat linked to spike in domestic violence calls in New Orleans, study finds
Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients
Physiology-guided complete revascularization in older patients with myocardial infarction
Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations
[Press-News.org] Nanoparticles that self-assemble at room temperature could transform vaccine deliveryResearchers from UChicago Pritzker Molecular Engineering created drug delivery nanoparticles that self-assemble with a simple temperature shift